• 1998

Company Description

Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.

Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiple sclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.

  • Manufacturer:

    Science and Engineering
  • Formed:

    1998
  • Company Website:

  • Company E-mail:

  • Company Address:

    Kungsängsvägen 25
    Sweden
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits